FORM DEF 14A

Company

DiaMedica Therapeutics Inc.

Filed

April 8, 2019

Period of Report

May 22, 2019

Accession Number

0001437749-19-006692

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →